Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The OTX2 Gene Induces Tumor Growth and Triggers Leptomeningeal Metastasis by Regulating the mTORC2 Signaling Pathway in Group 3 Medulloblastomas.
Int J Mol Sci. 2024 Apr 17;25(8):4416. doi: 10.3390/ijms25084416.
Int J Mol Sci. 2024.
PMID: 38674001
Free PMC article.
Extracellular-Vesicle-Based Cancer Panels Diagnose Glioblastomas with High Sensitivity and Specificity.
Mut M, Adiguzel Z, Cakir-Aktas C, Hanalioğlu Ş, Gungor-Topcu G, Kiyga E, Isikay I, Sarac A, Soylemezoglu F, Strobel T, Ampudia-Mesias E, Cameron C, Aslan T, Tekirdas E, Hayran M, Oguz KK, Henzler C, Saydam N, Saydam O.
Mut M, et al. Among authors: ampudia mesias e.
Cancers (Basel). 2023 Jul 26;15(15):3782. doi: 10.3390/cancers15153782.
Cancers (Basel). 2023.
PMID: 37568598
Free PMC article.
Item in Clipboard
SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma.
Ampudia-Mesias E, El-Hadad S, Cameron CS, Wöhrer A, Ströbel T, Saydam N, Saydam O.
Ampudia-Mesias E, et al.
Cancers (Basel). 2022 Apr 14;14(8):1984. doi: 10.3390/cancers14081984.
Cancers (Basel). 2022.
PMID: 35454889
Free PMC article.
Item in Clipboard
Correction to: CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.
Ampudia-Mesias E, Puerta-Martinez F, Bridges M, Zellmer D, Janeiro A, Strokes M, Sham YY, Taher A, Castro MG, Moertel CL, Pluhar GE, Olin MR.
Ampudia-Mesias E, et al.
Neurotherapeutics. 2021 Jul;18(3):2131. doi: 10.1007/s13311-021-01062-1.
Neurotherapeutics. 2021.
PMID: 33929711
Free PMC article.
No abstract available.
Item in Clipboard
CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.
Ampudia-Mesias E, Puerta-Martinez F, Bridges M, Zellmer D, Janeiro A, Strokes M, Sham YY, Taher A, Castro MG, Moertel CL, Pluhar GE, Olin MR.
Ampudia-Mesias E, et al.
Neurotherapeutics. 2021 Jul;18(3):1980-1994. doi: 10.1007/s13311-021-01038-1. Epub 2021 Apr 7.
Neurotherapeutics. 2021.
PMID: 33829411
Free PMC article.
Item in Clipboard
CD200 Checkpoint Reversal: A Novel Approach to Immunotherapy.
Xiong Z, Ampudia Mesias E, Pluhar GE, Rathe SK, Largaespada DA, Sham YY, Moertel CL, Olin MR.
Xiong Z, et al. Among authors: ampudia mesias e.
Clin Cancer Res. 2020 Jan 1;26(1):232-241. doi: 10.1158/1078-0432.CCR-19-2234. Epub 2019 Oct 17.
Clin Cancer Res. 2020.
PMID: 31624103
Item in Clipboard
Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma.
Olin MR, Ampudia-Mesias E, Pennell CA, Sarver A, Chen CC, Moertel CL, Hunt MA, Pluhar GE.
Olin MR, et al. Among authors: ampudia mesias e.
Cancers (Basel). 2019 Jan 24;11(2):137. doi: 10.3390/cancers11020137.
Cancers (Basel). 2019.
PMID: 30682795
Free PMC article.
Item in Clipboard
Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.
Xiong Z, Ampudia-Mesias E, Shaver R, Horbinski CM, Moertel CL, Olin MR.
Xiong Z, et al. Among authors: ampudia mesias e.
Immunotherapy. 2016 Sep;8(9):1059-71. doi: 10.2217/imt-2016-0033.
Immunotherapy. 2016.
PMID: 27485078
Free PMC article.
Item in Clipboard
Cite
Cite